Argus Investors' Counsel, Inc. Emergent Bio Solutions Inc. Transaction History

Argus Investors' Counsel, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 30, 2021	SELL	$56.61 - $80.46 $402,949 - $572,714	-7,118 Closed	0 $0
Q1 2021 Apr 19, 2021	SELL	$86.23 - $125.19 $63,379 - $92,014	-735 Reduced 9.36%	7,118 $661,000
Q4 2020 Jan 27, 2021	BUY	$79.17 - $111.47 $17,654 - $24,857	223 Added 2.92%	7,853 $704,000
Q3 2020 Oct 30, 2020	SELL	$81.91 - $134.94 $273,415 - $450,429	-3,338 Reduced 30.43%	7,630 $788,000
Q2 2020 Jul 27, 2020	BUY	$54.33 - $89.52 $97,250 - $160,240	1,790 Added 19.5%	10,968 $867,000
Q1 2020 Apr 24, 2020	BUY	$49.34 - $68.76 $452,842 - $631,079	9,178 New	9,178 $531,000

160

33.8M

453K

931K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $420M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of Argus Investors' Counsel, Inc., based on Form 13F filings with the SEC.

Stay updated on Argus Investors' Counsel, Inc. with notifications on news.